Pharmaceutical Industry
Health‘It felt like we were talking to statues’: An OxyContin addict who confronted the Sackler family about opioids reveals their stoicism
By Carmela ChirinosMarch 16, 2022
By Christiaan HetznerMarch 8, 2022
CommentaryLawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them
By Andrei Iancu, David J. Kappos and Paul R. MichelMarch 4, 2022
By Arthur Allen and Kaiser Health NewsFebruary 16, 2022
By Howard DeanFebruary 3, 2022
CommentaryInequity in health care made the AIDS crisis worse. Why are we making the same mistake with COVID-19?
By Jennifer LotitoJanuary 31, 2022
HealthThere’s a silent epidemic killing over 100,000 Americans a year, and the government is allowing the cure to get more and more expensive
By Andrew MarquardtJanuary 31, 2022
NewslettersWhat a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By Jeremy Kahn and Jonathan VanianJanuary 25, 2022
By Christiaan HetznerJanuary 21, 2022
By Ricardo Alonso-Zaldivar and The Associated PressJanuary 10, 2022
HealthSanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
By Andrei IancuDecember 24, 2021
Most Popular
